Wednesday, August 13, 2014

Top 5 Stocks To Invest In Right Now

VeriFone Systems Inc (NYSE:PAY) has a difficult road ahead as well as a litany of existing issues in order to complete the turnaround effort. The company is placing its bet on better managing the hardware business and introducing Payments-as-a-Service to revive its fortunes.

San Jose, California-based VeriFone makes global point of sale (POS) terminals and provides a wide array of hardware, service, and data security offerings that enable electronic payments processing for the global payments industry.

Issues at VeriFone run deeper than just certification problems, as inferior products, pricing pressure, elongated sales cycles and secular headwinds towards mPOS continue to plague the company. Verifone named Paul Galant as CEO in September to turnaround the company.

Best Up And Coming Companies To Watch For 2015: BB&T Corp (BBT)

BB&T Corporation (BB&T) is a financial holding company. BB&T conducts its business operations primarily through its commercial bank subsidiary, Branch Banking and Trust Company (Branch Bank), which has offices in North Carolina, Virginia, Florida, Georgia, Maryland, South Carolina, Alabama, West Virginia, Kentucky, Tennessee, Texas, Washington D.C and Indiana. In addition, BB&T�� operations consist of a federally chartered thrift institution, BB&T Financial, FSB (BB&T FSB), and a number of nonbank subsidiaries, which offer financial services products. BB&T�� operations are divided into six business segments: Community Banking, Residential Mortgage Banking, Dealer Financial Services, Specialized Lending, Insurance Services, and Financial Services. Branch Bank provides a range of banking and trust services for retail and commercial clients in its geographic markets, including small and mid-size businesses, public agencies, local Governments and individuals, through 1,779 offices as of December 31, 2011. During the year ended December 31, 2011, BB&T announced the acquisitions of Liberty Benefit Insurance Services, Atlantic Risk Management Corporation and the Precept Group. In April 2012, it acquired the life and property and casualty insurance operating divisions of Roseland, New Jersey - based Crump Group Inc. On July 31, 2012, it acquired BankAtlantic.

As of December 31, 2011, the principal operating subsidiaries of BB&T included Branch Banking and Trust Company, Winston-Salem, North Carolina; BB&T Financial, FSB, Columbus, Georgia; Scott & Stringfellow, LLC, Richmond, Virginia; Clearview Correspondent Services, LLC, Richmond, Virginia; Regional Acceptance Corporation, Greenville, North Carolina; American Coastal Insurance Company, Davie, Florida, and Sterling Capital Management, LLC, Charlotte, North Carolina. Branch Bank�� principal operating subsidiaries include BB&T Equipment Finance Corporation, BB&T Investment Services, Inc., BB&T Insurance Services, Inc., Stanley, Hunt, DuPree! & Rhine (a division of Branch Bank), Prime Rate Premium Finance Corporation, Inc., Grandbridge Real Estate Capital, LLC, Lendmark Financial Services, Inc., CRC Insurance Services, Inc. and McGriff, Seibels & Williams, Inc.

Community Banking

BB&T�� Community Banking serves individual and business clients by offering a range of loan and deposit products and other financial services. As of December 31, 2011, Community Banking had a network of 1,779 banking.

Residential Mortgage Banking

Residential Mortgage Banking segment retains and services mortgage loans originated by Community Banking, as well as those purchased from various correspondent originators. Mortgage loan products include fixed and adjustable rate Government and conventional loans for the purpose of constructing, purchasing or refinancing residential properties. Substantially all of the properties are owner occupied. BB&T retains the servicing rights to all loans sold. Residential Mortgage Banking earns interest on loans held in the warehouse and portfolio, fee income from the origination and servicing of mortgage loans and recognizes gains or losses from the sale of mortgage loans. BB&T�� mortgage originations totaled $23.7 billion in 2011. BB&T�� residential mortgage servicing portfolio, which includes both retained loans and loans serviced for third parties, totaled $91.6 billion in 2011.

Dealer Financial Services

Dealer Financial Services originates loans to consumers on a prime and nonprime basis for the purchase of automobiles. Such loans are originated on an indirect basis through approved franchised and independent automobile dealers throughout the BB&T market area and nationally through Regional Acceptance Corporation. This segment also originates loans for the purchase of boats and recreational vehicles originated through dealers in BB&T�� market area. In addition, financing and servicing to dealers for their inventories is provided through a ! joint rel! ationship between Dealer Financial Services and Community Banking.

Specialized Lending

BB&T�� Specialized Lending consists of eight business units that provide specialty finance products to consumers and businesses. The internal business units include Commercial Finance that contains commercial finance and mortgage warehouse lending; and, Governmental Finance that is responsible for tax-exempt Government finance. Operating subsidiaries include BB&T Equipment Finance which provides equipment leasing within BB&T�� banking footprint; Sheffield Financial, a division of FSB Financial, a dealer-based financer of equipment for both small businesses and consumers; Lendmark Financial Services, a direct consumer finance lending company; Prime Rate Premium Finance Corporation, which includes AFCO and CAFO, insurance premium finance business units that provide funding to businesses in the United States and Canada and to consumers in certain markets within BB&T�� banking footprint, and Grandbridge Real Estate Capital, a commercial mortgage banking lender providing loans on a national basis.

Insurance Services

BB&T Insurance Services provides property and casualty, life and health insurance to businesses and individuals. It also provides small business and corporate products, such as workers compensation and professional liability, as well as surety coverage and title insurance. In addition, Insurance Services also underwrites a limited amount of property and casualty coverage.

Financial Services

Financial Services provides personal trust administration, estate planning, investment counseling, wealth management, asset management, employee benefits services, corporate banking and corporate trust services to individuals, corporations, institutions, foundations and Government entities. Financial Services also offers clients investment alternatives, including discount brokerage services, equities, fixed-rate and variable-rate annuiti! es, mutua! l funds and governmental and municipal bonds through BB&T Investment Services, Inc., a subsidiary of Branch Bank. Financial Services includes Scott & Stringfellow, LLC, a brokerage and investment banking firm. Scott & Stringfellow provides services in retail brokerage, equity and debt underwriting, investment advice, corporate finance and equity research and facilitates the origination, trading and distribution of fixed-income securities and equity products in both the public and private capital markets. Scott & Stringfellow also has a public finance department that provides investment banking services, financial advisory services and municipal bond financing. Scott & Stringfellow�� investment banking and corporate and public finance areas conduct business as BB&T Capital Markets. This segment includes BB&T Capital Partners that is a group of BB&T-sponsored private equity and mezzanine investment funds that invest in privately owned middle-market operating companies. Financial Services also includes the Corporate Banking Division that originates and services corporate relationships, syndicated lending relationships and client derivatives.

Advisors' Opinion:
  • [By Rich Smith]

    Few regional banking stocks in the U.S. today cost more than BB&T (NYSE: BBT  ) stock. Indeed, the stock's biggest distinguishing factor is probably its priciness. Valued at 14.1 times trailing earnings, shares of BB&T cost 14% more than bigger rival US Bancorp (NYSE: USB  ) , and 33% more than smaller Fifth Third Bancorp (NASDAQ: FITB  ) . But is there a good reason for investors to pay up for BB&T stock?

  • [By Jay Jenkins]

    A consortium of banks, lead by Citigroup (NYSE: C  ) , Bank of America (NYSE: BAC  ) , BB&T (NYSE: BBT  ) , U.S. Bancorp (NYSE: USB  ) , and KeyCorp (NYSE: KEY  ) have joined forces to develop critical technology to pave the way for true mobile banking.�

  • [By Eric Volkman]

    The vault is open at BB&T (NYSE: BBT  ) and dividends are flowing to investors. The financial services company has declared its latest set of distributions, most prominently a common stock payout of $0.23 per share. It will also hand out disbursements to holders of its Series D, E, F, and G preferred stock. For Series D, this will amount to $365.625 (the equivalent of $00.365625 per depositary share, which represents 1/1000th interest in the underlying security). For Series E, $351.5625 ($0.3515625), and for both Series F and G, $325.00 ($0.325).

Top 5 Stocks To Invest In Right Now: CVS Corporation(CVS)

CVS Caremark Corporation operates as a pharmacy services company in the United States. The company?s Pharmacy Services segment provides a range of pharmacy benefit management services, including mail order pharmacy services, specialty pharmacy services, plan design and administration, formulary management, and claims processing; and drug benefits to eligible beneficiaries under the Federal Government?s Medicare Part D program. This segment primarily serves employers, insurance companies, unions, government employee groups, managed care organizations and other sponsors of health benefit plans, and individuals. As of December 31, 2010, it operated 44 retail specialty pharmacy stores, 18 specialty mail order pharmacies, and 4 mail service pharmacies located in 25 states, Puerto Rico, and the District of Columbia. This segment operates business under the CVS Caremark Pharmacy Services, Caremark, CVS Caremark, CarePlus CVS/pharmacy, CarePlus, RxAmerica, Accordant, and TheraCom names. The company?s Retail Pharmacy segment sells prescription drugs, over-the-counter drugs, beauty products and cosmetics, seasonal merchandise, greeting cards, and convenience foods through its pharmacy retail stores and online, as well as offers film and photo finishing, and health care services. This segment operated 7,182 retail drugstores located in 41 states, Puerto Rico, and the District of Columbia; and 560 retail health care clinics in 26 states and the District of Columbia under the MinuteClinic name. It has a strategic alliance with Alere, L.L.C. for the management of disease management program offerings that cover chronic diseases, such as asthma, diabetes, congestive heart failure, and coronary artery disease. CVS Caremark Corporation was founded in 1892 and is based in Woonsocket, Rhode Island.

Advisors' Opinion:
  • [By Mike Deane]

    At CVS Caremark Corporation’s (CVS) annual analyst day, the company reaffirmed its 2013 guidance and gave guidance for full year 2014, and also announced a 22% dividend raise and a stock repurchase program.

    Dividend Raise

    CVS will now be a quarterly dividend of 27.5 cents, which is up from its previous payout of 22.5 cents. The company’s dividend is payable on February 3, 2014 to all shareholders on record as of January 23, 2014.

    Stock Buyback

    CVS Caremark’s board of directors also approved up to $6 billion in share repurchases of the company’s common stock. The repurchase plan will be completed over a multi-year period and allows the company to make repurchases from time to time through “open market repurchases, privately negotiated transactions, accelerated share repurchase transactions, and/or other derivative transactions.”

    Guidance

    Dave Denton, CVS Caremark’s executive vice president and CFO, reaffirmed CVS’s views for 2013 and gave guidance for FY2014. For FY2014 the company expects EPS from continuing operations in the range of $4.36 to $4.50, and expects GAAP diluted EPS to fall in the range of $4.09 to $4.23.

    Stock Performance

    CVS stock was inactive in pre-market trading. YTD, the company’s stock is up 34.48%.

  • [By Johanna Bennett]

    CVS Caremark (CVS) rose 1% to $66.77 after it said it would buy medical provider Coram LLC to continue its push into the specialty-drug market.

    Tesla Motors (TSLA) rose 5.3% to $126.94 after analysts at Bank of America Merrill Lynch and Deutsche Bank posted opposing notes.

  • [By Shauna O'Brien]

    CVS Caremark Corporation (CVS) reported on Wednesday that it has agreed to acquire infusion services and nutrition business Coram LLC for $2.1 billion.

    CVS will purchase Coram from Apria Healthcare Group Inc in a deal that will likely close in the first quarter of 2014. CVS said that this acquisition is expected to add $1.4 billion to revenue in the first year and 3 to 5 cents per share in 2015. This purchase is in-line with the company strategy of focusing on core businesses that will drive growth.

    Jon Roberts, President of CVS Caremark Pharmacy Services said in a statement: “Bringing together CVS Caremark’s unique range of specialty pharmacy services with Coram’s infusion capabilities will expand our competitive offerings in the specialty arena. Infusion will be a valuable component of our broad specialty pharmacy offering going forward. Our comprehensive services will enable us to streamline care management for patients as well as their physicians, leading to better health outcomes while avoiding unnecessary costs.”

    CVS Caremark shares were mostly flat during pre-market trading Wednesday. The stock is up 27% YTD.

Top 5 Stocks To Invest In Right Now: Western Gas Equity Partners LP (WGP)

Western Gas Equity Partners, LP, incorporated on September 11, 2007, was formed to own three types of partnership interests in Western Gas Partners, LP (WES). WES is a limited partnership formed by Anadarko Petroleum Corporation to own, operate, acquire and develop midstream energy assets. As of December 31, 2011, the Company had no independent operations. On January 13, 2012, WES acquired 100% interest of Mountain Gas Resources LLC (MGR). On August 1, 2012, WES acquired 24% interest of Chipeta Processing LLC (Chipeta).

WES is engaged in the business of gathering, processing, compressing, treating and transporting natural gas, condensate, natural gas liquids (NGLs) and crude oil for Anadarko, as well as third-party producers and customers. The assets of WGP, through its partnership interests in WES, include thirteen gathering systems, seven natural gas treating facilities, ten natural gas processing facilities, two NGL pipelines, one interstate gas pipeline, one intrastate gas pipeline, and three separate interests in Fort Union, White Cliffs Pipeline, LLC (White Cliffs) and Rendezvous Gas Services, LLC (Rendezvous). These assets are located in East and West Texas, the Rocky Mountains (Colorado, Utah and Wyoming), and the Mid-Continent (Kansas and Oklahoma). WES also has facilities under construction in South Texas and northeast Colorado. During the year ended December 31, 2011, WES completed the construction of a cryogenic processing train at its Chipeta facility , which had a designed capacity of approximately 300 million cubic feet of natural gas per day and was placed into service in October 2012.

Advisors' Opinion:
  • [By Jonas Elmerraji]

    The exact same setup is potentially giving traders a reason to jump into shares of $8.5 billion midstream gas company Western Gas Equity Partners (WGP). Just like Flotek, WGP is forming a textbook channel up. And this week, Western Gas is testing trendline support.

    It's a little too early to call WGP's trendline buyable here. At some point, all trends eventually fail -- and when this one does, you don't want to be left holding the bag. A bounce this week will be a good indication that WGP can still catch a bid at this price level. When and if that happens, I'd recommend keeping a tight protective stop in place just below WGP's most recent swing low at $38.

    While the 50-day moving average has been crossing paths with WGP quite a bit in the last month, I'd recommend ignoring it. The average hasn't acted as a meaningful support or resistance level to date. In the case of this particular name, it's just not technically relevant.

Top 5 Stocks To Invest In Right Now: Spectral Diagnostics Inc (DIAGF)

Spectral Diagnostics Inc. (Spectral), incorporated on July 29, 1991, focuses on the development and commercialization, in North America, treatment for severe sepsis and septic shock. The Company also manufactures and sells certain reagents. Its products include Rapid Diagnostics for Sepsis, Endotoxin Activity Assay (EAA) and Toraymyxin. As of December 31, 2011, Spectral�� EAA endotoxin measurement was the only the United Sates Food and Drug Administration (FDA) cleared diagnostic on the market. Spectral Diagnostics (US) Inc. and Spectral Diagnostics (New Brunswick) Inc. are its subsidiaries.

The Company has developed a rapid diagnostic test for detection of components of gram negative bacterial cell wall (endotoxin). The EAA instrument is manufactured under contract for use in the hospital setting. The Toraymyxin hemoperfusion device removes endotoxin from the bloodstream and is manufactured by Toray Industries Inc. of Japan. The product is sold in Japan and Europe and has been used over 80,000 patients worldwide. As of December 31, 2011, Spectral was conducting clinical trials for the purpose of seeking regulatory approval in the United States. Spectral develops, produces and markets recombinant proteins, antibodies and calibrators. These materials are sold for use in research and development, as well as in products manufactured by other diagnostic companies. Royalty revenues are earned from these license arrangements based on a percentage of end user sales of Troponin I.

The Company competes with Eli Lilly, Agennix AG, AstraZeneca, Eisai, Gambro, InflammaGen Therapeutics, Fresenius and CytoSorbents.

Advisors' Opinion:
  • [By maarnio]

    Spectral Diagnostics (DIAGF) develops and commercializes theranostic treatment for severe sepsis in North America.

    Shares outstanding (March 31, 2014)

No comments:

Post a Comment